Table 2.
Top 5 most cited references of publications on genetic diagnosis and therapy of hereditary heart disease (HHD).
| Ranking | Title | Journals | Publication year | TC | First author |
|---|---|---|---|---|---|
| 1 | Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology | Genetics in medicine | 2015 | 19217 | Sue Richards, Chair |
| 2 | 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy | Heart rhythm | 2019 | 446 | Jeffrey A. Towbin |
| 3 | 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy the task force for the diagnosis and management of hypertrophic cardiomyopathy of the european society of cardiology (ESC) | European heart journal | 2014 | 3260 | Perry M. Elliott |
| 4 | Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy | New England journal of medicine | 2018 | 1479 | Mathew S. Maurer |
| 5 | Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe) | Circulation | 2018 | 452 | Carolyn Y. Ho |
TC, total citations.